Developing neolignans as proangiogenic agents: Stereoselective total syntheses and preliminary biological evaluations of the four guaiacylglycerol 8-O-4'-coniferyl ethers
| dc.contributor.author | Buckler, Joshua | |
| dc.contributor.author | Banwell, Martin | |
| dc.contributor.author | Kordbacheh, Farzaneh | |
| dc.contributor.author | Parish, Christopher | |
| dc.contributor.author | Santiago, Fernando | |
| dc.contributor.author | Khachigian, Levon M | |
| dc.date.accessioned | 2021-01-05T00:06:07Z | |
| dc.date.available | 2021-01-05T00:06:07Z | |
| dc.date.issued | 2017 | |
| dc.date.updated | 2020-11-23T10:25:04Z | |
| dc.description.abstract | Stereoselective total syntheses of the four stereoisomeric forms of guaiacylglycerol 8-O-4′-coniferyl ether, viz., compounds 1, ent- 1, 2, and ent- 2, have been established. The key step involves an Evans/Seebach auxiliarycontrolled and syn-selective aldol process followed, in the reaction sequences leading to the anti-compounds, by a Mitsunobu reaction involving a benzylic alcohol residue. The proangiogenic properties of the synthetic materials were evaluated in a human microvascular endothelial cell tubule formation assay, thus revealing that they are all active, with the 8S-configured compounds 1 and 2 being the most potent. | en_AU |
| dc.description.sponsorship | We thank the National Health and Medical Research Council, the Australian Research Council, and the Institute of Advanced Studies for financial support. J.N.B. is the grateful recipient of a Ph.D. Scholarship provided by the Australian Government. Dr. Hideki Onagi is thanked for assistance with chiral HPLC analyses. L.M.K. is a NH&MRC Australia Fellow. | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 2470-1343 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/219095 | |
| dc.language.iso | en_AU | en_AU |
| dc.provenance | This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. | en_AU |
| dc.publisher | ACS Publications | en_AU |
| dc.relation | http://purl.org/au-research/grants/arc/DP150101947 | en_AU |
| dc.rights | © 2017 American Chemical Society | en_AU |
| dc.rights.license | ACS AuthorChoice License | en_AU |
| dc.rights.uri | https://pubs.acs.org/page/policy/authorchoice_termsofuse.html | en_AU |
| dc.source | ACS Omega | en_AU |
| dc.title | Developing neolignans as proangiogenic agents: Stereoselective total syntheses and preliminary biological evaluations of the four guaiacylglycerol 8-O-4'-coniferyl ethers | en_AU |
| dc.type | Journal article | en_AU |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.issue | 10 | en_AU |
| local.bibliographicCitation.lastpage | 7388 | en_AU |
| local.bibliographicCitation.startpage | 7375 | en_AU |
| local.contributor.affiliation | Buckler, Joshua, College of Science, ANU | en_AU |
| local.contributor.affiliation | Banwell, Martin, College of Science, ANU | en_AU |
| local.contributor.affiliation | Kordbacheh, Farzaneh, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Parish, Christopher, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Santiago, Fernando, University of New South Wales | en_AU |
| local.contributor.affiliation | Khachigian, Levon M, University of New South Wales | en_AU |
| local.contributor.authoruid | Buckler, Joshua, u5064427 | en_AU |
| local.contributor.authoruid | Banwell, Martin, u9500594 | en_AU |
| local.contributor.authoruid | Kordbacheh, Farzaneh, u4650483 | en_AU |
| local.contributor.authoruid | Parish, Christopher, u6900322 | en_AU |
| local.description.notes | Imported from ARIES | en_AU |
| local.identifier.absfor | 111502 - Clinical Pharmacology and Therapeutics | en_AU |
| local.identifier.absfor | 110101 - Medical Biochemistry: Amino Acids and Metabolites | en_AU |
| local.identifier.absseo | 920103 - Cardiovascular System and Diseases | en_AU |
| local.identifier.ariespublication | u4351680xPUB461 | en_AU |
| local.identifier.citationvolume | 2 | en_AU |
| local.identifier.doi | 10.1021/acsomega.7b01459 | en_AU |
| local.identifier.scopusID | 2-s2.0-85032622239 | |
| local.publisher.url | http://pubs.acs.org/journal/acsodf | en_AU |
| local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- 01_Buckler_Developing_neolignans_as_2017.pdf
- Size:
- 1020.75 KB
- Format:
- Adobe Portable Document Format